To further verify their findings, IHC was performed in GIST patient tissue with a finding of significant expression of SPRY4 in metastatic GIST cases (n=7) compared with resected primary GIST cases (n=8). This evidence concerns the gene SPRY4 and gastrointestinal stromal tumor.